An Open-label, Single-center Trial to Evaluate Systemic Exposure of Catechins From Commercially Available, Topically Applied Veregen 15% Ointment in Patients With External Anogenital Warts and From Oral Intake of Green Tea Beverage in Healthy Volunteers.

Trial Profile

An Open-label, Single-center Trial to Evaluate Systemic Exposure of Catechins From Commercially Available, Topically Applied Veregen 15% Ointment in Patients With External Anogenital Warts and From Oral Intake of Green Tea Beverage in Healthy Volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 18 Apr 2012

At a glance

  • Drugs Green tea; Polyphenon E
  • Indications Viral infections; Warts
  • Focus Pharmacokinetics
  • Sponsors MediGene Inc
  • Most Recent Events

    • 18 Apr 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 15 Dec 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top